The Johnson & Johnson Vaccine Stimulates A Strong Immune Response To Prevent Corona

nterim results published yesterday showed that a single dose of Johnson & Johnson’s experimental Covid-19 vaccine stimulated a strong immune response to prevent the emerging corona virus, in an early to medium-stage clinical trial.

The results showed that the vaccine, called AD26. Kov2S, was equally well tolerated in two different doses.

But it is not clear if the elderly, who are one of the population groups most at risk of contracting the virus, will enjoy the same protection as younger people from the J&J vaccine.

The trial of nearly a thousand healthy adults, which is supported by the US government, began after it was discovered in July that a single dose of the vaccine provides strong protection for monkeys.

Based on the current results, the company on Wednesday began a final trial with 60,000 people that could pave the way to apply for regulatory approval. The company said it expects the results of the so-called Phase III trial by the end of the year or early next year.

 

Source: kuwaitofferings

Comments Post Comment

Leave a Comment

Submit